newsfilter
← Latest News
PR Newswire·

Protalix BioTherapeutics Issues 2025 Letter to Stockholders

Protalix BioTherapeutics, Inc. (NYSE-American: PLX), a biopharmaceutical company focused on the development, production and commercialization of...